// App-Quantinova.ai

P1576 : A PHASE 3 RANDOMIZED, DOUBLE-BLIND, COMPARATOR-CONTROLLED STUDY TO EVALUATE SAFETY, TOLERABILITY AND IMMUNOGENICITY OF V114 PNEUMOCOCCAL VACCINE IN HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS (PNEU-STEM)

Researchers

Presenter

  • Marissa Wilck

Principal Investigators

  • Oliver Cornely

  • Per Ljungman

  • Catherine Cordonnier

  • Ron Dagan

  • Tina Sterling

  • Tulin Shekar

  • Ulrike Buchwald

Medical Centers

  • University Clinic Cologne,Cologne,Allemagne

  • CHU Henri Mondor, Creteil, France

  • CHU Henri Mondor, Creteil, France

  • Co., Inc.,Kenilworth,United States

  • University Clinic Cologne,Cologne,Deutschland

  • Fundacion Valle del Lili,Cali,Колумбия

  • University Clinic Cologne,Cologne,Deutschland

  • University Clinic Cologne,Cologne,Германия

  • Karolinska University Hospital, Stockholm, Sweden

  • University of Western Australia,Perth,Australië

  • Merck &amp

  • Karolinska University Hospital, Stockholm, Sweden

  • Ben Gurion University, Beer Sheva, Israel

  • University Clinic Cologne,Cologne,Allemagne

  • CHU Henri Mondor, Creteil, France

  • University Clinic Cologne,Cologne,Allemagne

  • University of Western Australia,Perth,Australië

  • University of Western Australia, Crawley, Australia

  • Co., Inc.,Kenilworth,Vereinigte Staaten

  • Co., Inc, Kenilworth, NJ

  • Ben Gurion University, Beer Sheva, Israel

  • Henri Mondor Hospital,Creteil,Frankrike

  • Fundacion Valle del Lili,Cali,哥伦比亚

  • Henri Mondor Hospital,Creteil,Frankrike

  • Co., Inc.,Kenilworth,Vereinigte Staaten

  • Ben-Gurion University ,Beer-Sheva,Израиль

  • University of Western Australia,Perth,Australië

  • Co., Inc.,Kenilworth, NJ,États-unis

  • Ben Gurion University, Beer Sheva, Israel

  • University Clinic Cologne,Cologne,Allemagne

  • Fundacion Valle del Lili, Cali, Colombia

  • Karolinska University Hospital, Stockholm, Sweden

  • University Clinic Cologne,Cologne,Allemagne

  • Karolinska University Hospital,Stockholm,Швеция

  • Karolinska University Hospital, Stockholm, Sweden

  • Fundacion Valle del Lili, Cali, Colombia

  • Co., Inc.,Kenilworth,Stati Uniti

  • Karolinska University Hospital, Stockholm, Sweden

  • Co., Inc.,Kenilworth,Estados Unidos

  • Karolinska Universi

  • Fundacion Valle del Lili, Cali, Colombia

  • Karolinska University Hospital, Stockholm, Sweden

  • Henri Mondor Hospital,Creteil,Франция

  • Fundacion Valle del Lili, Cali, Colombia

  • University of Western Australia,Perth,Australië

  • University of Western Australia,Perth,Австралия

  • University Clinic Cologne,Cologne,Allemagne

  • Karolinska University Hospital, Stockholm, Sweden

  • University of Ulm

  • Henri Mondor Hospital,Creteil,Frankrike

Locations

  • United Kingdom

  • United States

  • Germany

  • Sweden

  • France

  • Colombia

  • Israel

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Graft-versus-host disease

Biomarkers

  • Hematocrit

  • Immunoglobulin G

Drug/Treatment

  • Pneumococcal polysaccharide vaccine

  • Intratect

  • 13-valent pneumococcal conjugate vaccine

  • Allopurinol

Outcome

  • N/A


Study Design

  • Randomized

  • Double Blind/Blinded

  • Controlled

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A